RAF1 and cancer: YM-1 exhibits anticancer activity by destabilizing oncoproteins such as Akt and Raf-1, demonstrating efficacy against various cancer cell lines with similar EC50 values, e.g., tamoxifen-resistant MCF7 breast cancer cells[146].